Search

    Select Website Language
    Defense Secretary Pete Hegseth has ordered the U.S. military to begin annual testosterone screenings for service members 30 and older—with optional testosterone replacement therapy (TRT) for anyone who tests low. The catch? This is the same administration that banned gender-affirming care for transgender troops. This week on Vibe Check, Saeed Jones and Zach Stafford break down Hegseth's testosterone policy, his obsession with masculinity and military iconography, and why banning trans healthcare while mandating TRT for cis men is one of the biggest contradictions in the Department of Defense—sorry, Department of War. Drawing on the reporting around Hegseth's fitness culture and his own military background, they also connect this to the larger "Gen Z delusion" debate going viral on TikTok—why naming a problem isn't the same as solving it, and what it actually takes to move from outrage to action. In this episode: - Hegseth's new military testosterone screening policy, explained - The contradiction: TRT for cis men, banned care for trans troops - Hegseth's obsession with Crusades iconography and military masculinity - How TRT and steroid culture are being marketed to young men - The "Gen Z delusion" TikTok theory—and why it's not just Gen Z - What the fight for marriage equality can teach us about grassroots pressure today 👇 Tell us in the comments: Is testosterone replacement therapy for cis men actually "gender-affirming care"? Subscribe to Vibe Check for new conversations every week on politics, culture, media, and the stories shaping our world. 🎧 Email us: vibecheck@stitcher.com 📱 Instagram: @vibecheck_pod 🔒 Join our Patreon: patreon.com/vibecheck 🎁 Free 3-month SiriusXM trial: siriusxm.com/vibecheck
    Previous Article
    Isaiah Martin SCHOOLS Trumper On The Economy
    Next Article
    Streaming Was Supposed To Kill Cable, But Now Viewers Pay More While Actors Get Less

    Related Podcast Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment